TABLE 3.
Demographics of children who received additional neuromuscular blockade reversal with comparison of African American children to Non‐African American children
| Demographics | African American (n = 25) | Non‐African American (n = 76) | p‐Value |
|---|---|---|---|
| Median [IQR] | Median[IQR] | ||
| Age (year) | 13.0 [1.00, 16.10] | 14.3 [9.43, 16.00] | 0.420 |
| Weight (kg) | 56.52 [12.02, 67.59] | 60.10 [35.02, 77.70] | 0.238 |
| Median train‐of‐four count value prior to initial reversal | 0 [0,3.5] (n = 21) |
1 [0,4] (n = 64) |
0.378 |
| N (%) | N (%) | ||
|---|---|---|---|
| Male | 12 (48.0) | 36 (47.4) | 0.890 |
| Inpatient | 7 (28.0) | 27 (35.5) | 0.627 |
| Emergency | 6 (24.0) | 20 (26.3) | 0.880 |
| Weight, <5th percentile or > 95th percentile | 8 (32.0) | 33 (43.4) | 0.439 |
| Elevated end‐tidal agent concentration | 3 (12.0) | 7 (9.2) | 0.985 |
| Off hours | 3 (12.0) | 11 (14.5) | 0.982 |
| Surgical case type | 0.367 a | ||
| ENT | 4 (16.0) | 5 (6.6) | ‐ |
| General | 11 (44.0) | 34 (44.7) | ‐ |
| Orthopedics | 5 (20.0) | 12 (15.8) | ‐ |
| Other | 5 (20.0) | 25 (32.9) | ‐ |
| Mean (SD) | Mean (SD) | ||
|---|---|---|---|
| Case length (minutes) | 135.56 (71.74) | 139.42 (81.59) | 0.833 |
| Initial neostigmine dose (mg kg−1) | 0.05 (0.02) | 0.05 (0.03) | 0.957 |
| Time from last rocuronium dose to initial neostigmine dose (minutes) | 55.80 (26.55) | 44.64 (34.67) | 0.230 |
| Cumulative rocuronium dose (mg kg−1 hr−1) | 0.46 (0.14) | 0.48 (0.24) | 0.713 |
| Cumulative rocuronium dose using ideal body weight | 0.73 (0.66) | 0.65 (0.44) | 0.541 |
Note: p < 0.05 considered significant. ENT = otolaryngologic or airway procedure.
a
p‐values based on 2 × 3 or 2 × 4 Chi‐square analysis.